Single Therapeutic and Supra‐Therapeutic Doses of Ubrogepant Do Not Affect Cardiac Repolarization in Healthy Adults: Results From a Randomized Trial

Clinical Pharmacology and Therapeutics - United States
doi 10.1002/cpt.1696
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley


Related search